2020
DOI: 10.3390/ijms21041499
|View full text |Cite
|
Sign up to set email alerts
|

Identification of MOR-Positive B Cell as Possible Innovative Biomarker (Mu Lympho-Marker) for Chronic Pain Diagnosis in Patients with Fibromyalgia and Osteoarthritis Diseases

Abstract: Fibromyalgia (FM) diagnosis follows the American College of Rheumatology (ACR) criteria, based on clinical evaluation and written questionnaires without any objective diagnostic tool. The lack of specific biomarkers is a tragic aspect for FM and chronic pain diseases in general. Interestingly, the endogenous opioid system is close to the immune one because of the expression of opioid receptors on lymphocytes membrane. Here we analyzed the role of the Mu opioid receptor on B lymphocytes as a specific biomarker … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
32
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 31 publications
(32 citation statements)
references
References 58 publications
0
32
0
Order By: Relevance
“…Although the huge amount of studies concerning this pathology, nowadays there is not a precise treatment for chronic pain [ 59 ]. Moreover, the lack of specific diagnostic tools makes chronic pain therapy really arduous [ 60 , 61 ] increasing the gap between preclinical and clinical results.…”
Section: Discussionmentioning
confidence: 99%
“…Although the huge amount of studies concerning this pathology, nowadays there is not a precise treatment for chronic pain [ 59 ]. Moreover, the lack of specific diagnostic tools makes chronic pain therapy really arduous [ 60 , 61 ] increasing the gap between preclinical and clinical results.…”
Section: Discussionmentioning
confidence: 99%
“…Apart from metabolomic changes 16 , 26 , Raffaeli et al . 27 identified a Mu opioid receptor, expressed on the B lymphocytes surface, as a biological marker (named Mu-Lympho-Maker) for an objective chronic pain diagnosis of fibromyalgia.…”
Section: Discussionmentioning
confidence: 99%
“…Recently, immunophenotyping analysis performed on blood samples of FM patients revealed a role of the Mu opioid receptor on B lymphocytes as a specific biomarker for FM [ 26 ]. Moreover, a rapid biomarker-based method for diagnosing FM has been developed by using vibrational spectroscopy to differentiate patients with FM from those with other pain-related diseases.…”
Section: Diagnosismentioning
confidence: 99%